FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016419370> ?p ?o ?g. }

• W2016419370 endingPage "e95" @default.
• W2016419370 startingPage "e95" @default.
• W2016419370 abstract "Based on their unique advantages, increasing interest has been shown in the use of aptamers as target ligands for specific cancer cell recognition and targeted cancer therapy. Recently, the development of aptamer-conjugated nanomaterials has offered new therapeutic opportunities for cancer treatment with better efficacy and lower toxicity. We highlight some of the promising classes of aptamer-conjugated nanomaterials for the specific recognition of cancer cells and targeted cancer therapy. Recent developments in the use of novel strategies that enable sensitive and selective cancer cell recognition are introduced. In addition to targeted drug delivery for chemotherapy, we also review how aptamer-conjugated nanomaterials are being incorporated into emerging technologies with significant improvement in efficiency and selectivity in cancer treatment. New methods of integrating aptamers with various types of nanomaterials are summarized, highlighting promising classes of aptamer-conjugated nanoparticles for efficient cancer cell recognition and the targeted delivery of drugs. In addition, emerging technologies for cancer treatment using nanomaterials as therapeutic drugs are discussed. These aptamer-conjugated nanomaterials will benefit cancer treatment through increased specificity and efficacy as well as reduced toxicity. A major challenge in cancer therapy is the selective targeting of cancerous cells to enhance treatment efficiency and reduce the side effects for patients. A variety of nanostructured materials have recently been developed that, when combined with ligands, are able to recognize the target cells through antigens or receptors. Qiaoling Liu from Hunan University and colleagues in China and the United States review the use of DNA aptamers as ligands. These short, synthetic oligonucleotide strands are cost-effective, exhibit low toxicity and can be attached to a range of nanomaterials - from liposomes and hydrogels to inorganic nanoparticles - to endow them with sensitive and selective cell-recognition abilities. Furthermore, the resulting hybrid nanomaterials can be used in conjunction with conventional treatments, such as photodynamic and photothermal therapies. Although hurdles in their toxicity and efficiency remain to be overcome before they are suitable for real-life cancer treatments, aptamer-conjugated nanomaterials have emerged as a promising theranostic platform." @default.
• W2016419370 created "2016-06-24" @default.
• W2016419370 creator A5002164849 @default.
• W2016419370 creator A5017825677 @default.
• W2016419370 creator A5024421064 @default.
• W2016419370 creator A5039414614 @default.
• W2016419370 creator A5043167767 @default.
• W2016419370 creator A5064414111 @default.
• W2016419370 creator A5083141761 @default.
• W2016419370 date "2014-04-01" @default.
• W2016419370 modified "2023-10-11" @default.
• W2016419370 title "Aptamer-conjugated nanomaterials for specific cancer cell recognition and targeted cancer therapy" @default.
• W2016419370 cites W1607665397 @default.
• W2016419370 cites W1969099652 @default.
• W2016419370 cites W1970645776 @default.
• W2016419370 cites W1973528774 @default.
• W2016419370 cites W1974183075 @default.
• W2016419370 cites W1978244778 @default.
• W2016419370 cites W1978762833 @default.
• W2016419370 cites W1980471937 @default.
• W2016419370 cites W1982207352 @default.
• W2016419370 cites W1986293641 @default.
• W2016419370 cites W1994316057 @default.
• W2016419370 cites W1994379261 @default.
• W2016419370 cites W1996497248 @default.
• W2016419370 cites W1997045968 @default.
• W2016419370 cites W1999910805 @default.
• W2016419370 cites W2002948107 @default.
• W2016419370 cites W2005768891 @default.
• W2016419370 cites W2008550028 @default.
• W2016419370 cites W2011030869 @default.
• W2016419370 cites W2013774795 @default.
• W2016419370 cites W2014941346 @default.
• W2016419370 cites W2015429786 @default.
• W2016419370 cites W2028204215 @default.
• W2016419370 cites W2029608148 @default.
• W2016419370 cites W2031133682 @default.
• W2016419370 cites W2031555302 @default.
• W2016419370 cites W2034192753 @default.
• W2016419370 cites W2034294773 @default.
• W2016419370 cites W2034416429 @default.
• W2016419370 cites W2038235861 @default.
• W2016419370 cites W2039684640 @default.
• W2016419370 cites W2040496909 @default.
• W2016419370 cites W2040627191 @default.
• W2016419370 cites W2041369731 @default.
• W2016419370 cites W2044560021 @default.
• W2016419370 cites W2046851174 @default.
• W2016419370 cites W2046866645 @default.
• W2016419370 cites W2048787739 @default.
• W2016419370 cites W2052606768 @default.
• W2016419370 cites W2055119381 @default.
• W2016419370 cites W2055494875 @default.
• W2016419370 cites W2056368730 @default.
• W2016419370 cites W2058574114 @default.
• W2016419370 cites W2059281433 @default.
• W2016419370 cites W2062322931 @default.
• W2016419370 cites W2073066818 @default.
• W2016419370 cites W2073883364 @default.
• W2016419370 cites W2075013879 @default.
• W2016419370 cites W2084064316 @default.
• W2016419370 cites W2085623438 @default.
• W2016419370 cites W2088277794 @default.
• W2016419370 cites W2095469093 @default.
• W2016419370 cites W2100181290 @default.
• W2016419370 cites W2104134927 @default.
• W2016419370 cites W2107119662 @default.
• W2016419370 cites W2115072986 @default.
• W2016419370 cites W2127046591 @default.
• W2016419370 cites W2127126241 @default.
• W2016419370 cites W2127693895 @default.
• W2016419370 cites W2128565250 @default.
• W2016419370 cites W2129360146 @default.
• W2016419370 cites W2129808949 @default.
• W2016419370 cites W2135694201 @default.
• W2016419370 cites W2136721466 @default.
• W2016419370 cites W2138732162 @default.
• W2016419370 cites W2144011335 @default.
• W2016419370 cites W2146352983 @default.
• W2016419370 cites W2149809916 @default.
• W2016419370 cites W2150641822 @default.
• W2016419370 cites W2152595252 @default.
• W2016419370 cites W2160714861 @default.
• W2016419370 cites W2164283028 @default.
• W2016419370 cites W2170669262 @default.
• W2016419370 cites W2172008662 @default.
• W2016419370 cites W2320409829 @default.
• W2016419370 cites W2331775465 @default.
• W2016419370 cites W2333692084 @default.
• W2016419370 cites W3196887107 @default.
• W2016419370 cites W4362094783 @default.
• W2016419370 doi "https://doi.org/10.1038/am.2014.12" @default.
• W2016419370 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5880215" @default.
• W2016419370 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29619132" @default.
• W2016419370 hasPublicationYear "2014" @default.
• W2016419370 type Work @default.
• W2016419370 sameAs 2016419370 @default.
• W2016419370 citedByCount "107" @default.

• next